aspirin and extended - release dipyridamole capsules, 25 mg / 200 mg

Generic: aspirin and extended - release dipyridamole

Labeler: endo usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name aspirin and extended - release dipyridamole capsules, 25 mg / 200 mg
Generic Name aspirin and extended - release dipyridamole
Labeler endo usa, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

aspirin 25 mg/1, dipyridamole 200 mg/1

Manufacturer
Endo USA, Inc.

Identifiers & Regulatory

Product NDC 49884-007
Product ID 49884-007_1f495553-0af4-49ab-89af-7cf5a5094d46
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA207944
Listing Expiration 2026-12-31
Marketing Start 2017-01-30

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 49884007
Hyphenated Format 49884-007

Supplemental Identifiers

RxCUI
259081
UNII
R16CO5Y76E 64ALC7F90C
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin and extended - release dipyridamole capsules, 25 mg / 200 mg (source: ndc)
Generic Name aspirin and extended - release dipyridamole (source: ndc)
Application Number ANDA207944 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
  • 200 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE (49884-007-02)
source: ndc

Packages (1)

Ingredients (2)

aspirin (25 mg/1) dipyridamole (200 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1f495553-0af4-49ab-89af-7cf5a5094d46", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E", "64ALC7F90C"], "rxcui": ["259081"], "spl_set_id": ["237a1f63-53ff-47fa-903c-ac6276e594a2"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Endo USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (49884-007-02)", "package_ndc": "49884-007-02", "marketing_start_date": "20170130"}], "brand_name": "Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg", "product_id": "49884-007_1f495553-0af4-49ab-89af-7cf5a5094d46", "dosage_form": "CAPSULE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "49884-007", "generic_name": "Aspirin and Extended - Release Dipyridamole", "labeler_name": "Endo USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg", "active_ingredients": [{"name": "ASPIRIN", "strength": "25 mg/1"}, {"name": "DIPYRIDAMOLE", "strength": "200 mg/1"}], "application_number": "ANDA207944", "marketing_category": "ANDA", "marketing_start_date": "20170130", "listing_expiration_date": "20261231"}